Archive by Author

An open letter to Congressman Posey

14 Jun

Congressman Bill Posey has an article on The Hill entitled: Fix the Combating Autism Act. I won’t copy the whole article here, but it begins:

Autism Spectrum Disorder has increased dramatically in the last 25 years. It is a crisis. What will legislators do with a federal program which, after eight years and $1.7 billion, has failed to truly address this crisis? Sadly, Washington is on a path to rush through a five-year reauthorization, raise spending 20 percent and hope for better results without addressing fundamental structural flaws in the current program.

I wrote a lengthy response to the article in the comments and I copy it below as an open letter to the Congressman.

As always, all comments and views are my own.

Congressman Posey,

I appreciate your attention to the autism communities, but I wish you would seek out and understand the positions of a greater number of viewpoints within the communities. So far, you appear to be listening primarily to the minority of parent-advocates who promote the failed idea of a vaccine-induced epidemic. The autism communities are much more broad than that. And our needs reflect that.

I notice that in this article you don’t mention vaccines, while elsehwere you have been vocal on this topic. I notice that the Coalition that you mention avoids discussion of vaccines as well, while their members are all very strong proponents of the failed notion of a vaccine-induced autism epidemic.

Are you aware that most autism parents do not believe that vaccines cause autism? About 40% recently answered that they felt this was a possible cause. Likely much fewer believe that vaccines were responsible for their own child’s autism.

And the science available says that minority is wrong. We have a limited amount of resources. While you may think of this in terms of money, I think of this in terms of quality researchers. There just aren’t that many to focus on all the questions of autism etiology. Should we keep going back to the question of autism and vaccines after over a decade of negative results?

If one wants to discuss failures, the failure of the vaccine-hypothesis is one of the greatest not within our communities, but within scientific research in general. Many millions of dollars, many researcher man-hours and again and again we see the same answer: no.

That was a lot of duplicative research. The studies approached the questions from various angles and replicated the answers. Questions have been posed and answered about thimerosal and the MMR–they do not increase autism risk. Those who lobby you for increased attention for vaccines deny the results of multiple studies, multiple groups.

You asked a question at a recent hearing. You asked about which studies have been performed on thimerosal without Poul Thorsen as an author. Why were you not aware of the many such studies? You or a staffer could easily use Pubmed and verify this. Much more to the point, why are you propagating this ad hominem attack on the autism-vaccine research? I decry the actions of Poul Thorsen. Not just as a taxpayer who doesn’t want to see money stolen. As an autism parent I decry his actions for feeding the groups who promote the idea of a vaccine-induced autism epidemic. In working on such important topics, Thorsen held a public trust and he betrayed that trust. The cost to Americans in general and to the autism communities in specific has been far greater than the value of the funds he took. Your statements are a part of the fallout of that damage.

Autism is a hugely important topic which deserves a great deal of attention. We don’t need to invoke epidemics or terms like “crisis” in order to take this seriously. We need accurate information. So far, we don’t really have accurate information on the prevalence and incidence of autism over time. A comment out this week in the scientific literature addresses exactly this issue: can we trust the autism prevalence estimates?

“I was recently made aware of some suggested changes proposed by a coalition of national autism organizations representing those children and adults most severely affected by autism, the Autism Reform Policy Coalition. These organizations represent those living with autism every day.”

With all due respect, these groups do not “represent those living with autism every day”. They are a coalition of small parent-advocate groups focused on the failed idea of a vaccine-induced epidemic of autism. There isn’t a group of autistics in the coalition. There isn’t a group with the majority view that vaccines are not involved in the etiology of autism. There isn’t a group that allows members to elect officers. They represent themselves, a small group of officers, many shared across the supposedly separate organizations listed in the coalition. They are vocal, but they do not represent the communities.

These groups also largely promote pseudo-medical “therapies” which include some which are useless and even harmful. Frankly, some are abusive. These “therapies” are often sold with the idea that they “heal vaccine injury”. This is why so many of us in the autism communities speak out against the vaccine-induced-autism-epidemic. The idea is not just wrong, it causes harm. A great deal of harm.

“At a recently called House Oversight Subcommittee meeting, Dr. Insel admitted that after eight years and spending $1.7 billion, the programs developed in the CAA have failed to determine the causes of the enormous increase of the prevalence of autism…”
I’ll let Dr. Insel respond to what he did or did not say in the hearing. I will say that he is very much aware of the research showing that at least a sizable fraction of the increase in the prevalence of identified autism is due to social influences. I know this because I’ve seen him interview one of the key researchers involved with this work.

We know that at least some of the increase is due to social influences. Note the phrase “at least”. Changes in the way we identify and classify autism have driven part of the increase. Changes in awareness also, some not quantified. And this is not limited to an expansion of autism to include more individuals without intellectual disability. A recent study looking at the UCLA/Utah data taken in the 1980’s showed that a large fraction of those with severe and profound intellectual disability were not recognized as autistic at the time.

The CDC estimates of the prevalence of identified autism always include large fractions of children who were not previously identified autistic.

Think about that–we have been misclassifying people for decades. There is a large population–adults and children–who are not getting the services and supports they need. If anything rises to the level of crisis, it is this. And yet the coalition you mention actively denies the existence of these unidentified autistics.

Think about that when you assert that they represent those affected by autism.

Is the actual fraction of the population with autism increasing? This is a very different question that the question of whether the fraction of the population identified with autism is increasing. We can answer the latter question–yes, we have many more identified with autism today than before. We can answer the “why” of that question at least in part–social influences have driven the rate of identified autism up. As to the former question–how much of the increase represents a “true” increase in autism prevalence, we don’t know. Two groups have estimated that between 4 and 11% of the increase is “real”. And likely genetic. Children of older parents have an increased risk of autism, and parents are having children later in life. Recall that Down Syndrome, a genetic condition, risk increases with maternal age.

Keep in mind, social influences are “real”. Understanding and quantifying those are important. For one, to help quantify a possible secular increase in autism incidence. For another, if we understand the social influences we can better identify those who remain under served and under supported.

Let’s look at the questions posed by the increase in identified autism. First, there are social influences and we should be responding to those data. Second, actual increases in autism incidence could include genetic etiologies. Will we ever know what the “true” prevalence of autism has been over history? Possibly (maybe even likely) not. But do we need an “epidemic” of autism to focus seriously on environmental risk factors? No. We do not. In fact, by focusing attention on the increased prevalence (which we know to be at least largely driven socially) we will not only be likely looking in the wrong place for drivers of increased prevalence, we will miss those risk factors which are not increasing with time.

Consider Congental Rubella Syndrome. Likely the first identified factor increasing autism risk. Is there a way to identify the impact of vaccination on the fraction of autism prevalence due to CRS? No. There’s just too much noise in the signal. But, researchers recently did quantify this–the number of autism cases *prevented* over the past decade by this simple public health measure.

To put things simply–there is no known environmental risk factor increasing autism prevalence. There are multiple social factors increasing the prevalence of identified autism. There are known genetic risk factors which increase the risk of autism. If we were to base our funding decisions on the data on hand, we would put little into environmental risk factors and more into social drivers and genetic research. I do not suggest this as a wise course of action. Instead I present this as an example of the failed and flawed logic of the Coalition. They would claim that genetic research has failed (it hasn’t) and that the basis for environmental risk factors is stronger than it is.

For the record, I sit on the IACC. My comments here and elsewhere are my own: they do not represent the views of the IACC. Having spent the past few years actively involved with the IACC, and years before that intently observing the IACC, I will say that the IACC does what Congress structured it to do. It does it well enough that other advocacy groups would like to emulate this effort. It does not–because it can not–direct which research actually gets performed.

But to suggest that the IACC strategic plan sits unread is false. You write:

“Instead, the IACC plan sits on a shelf while the NIH actually funds autism research through an entirely different set of processes and priorities, completely divorced from the strategic plan. ”

This poses many questions. First, have you read the Plan? You suggest that when you state that it sits on a shelf. If not, why not? Second, to state this ignores the process through which the Plan is drafted. The federal members of the IACC include representatives from most of the agencies which fund autism research. Directors of various Institutes of the NIH, CDC, representatives from DoD and FDA not only are present for the drafting of the Plan, they participate in the process. Decision makers in the Federal Government are well aware of the Strategic Plan.

With all due respect, the phrase “while the NIH actually funds autism research through an entirely different set of processes and priorities, completely divorced from the strategic plan ” is just plain incorrect. First, funders of autism research within the Federal government are not limited to the NIH. Second, the data speaks for itself: the vast majority of topics in the Plan are funded. Some underfunded, some overfunded. But funded. Are we to assume this is just a random coincidence?

Consider if you will just one of the outside funders of autism research: the Simons Foundation. Much of their focus has been on genetics. Their contribution has been very substantial. Rather than attack the focus on genetics research and claim (incorrectly as many in the Coalition have done) that genetics research has not been fruitful, I say thank you, very much, to private funders for the research they have funded in genetics and elsewhere.

While on the topic of genetics, there are two myths promoted by groups such as those in the Coalition. First, that there can be no genetic epidemic. This is not true, as genetically driven risk factors due to aging parents can drive a “true” increase in autism prevalence. The second myth is that genetic conditions are not treatable while environmental caused conditions are. As a person with an environmentally caused disability, I can say that with certainty that environmental does not equate with treatable. As to genetic conditions, one of the hot areas of autism treatment research has involved Fragile-X syndrome, a genetic condition. People with Down Syndrome, a genetic condition, are living longer and healthier lives due to a better understanding of the health conditions associated with DS. If we ignore genetic research, as those on the Coalition urge us to do, we close the doors to many potential avenues for treatment research.

We don’t need to label autism as a “crisis” or an “epidemic” to take it seriously. Likely, about 2.5% of the population is autistics. A sizable minority whose substantial needs deserve attention. Much more, what has become increasingly more obvious over the past decade: the needs of that 2.5% are very diverse. Research focused on, say, the important topic of supporting young adults in the mainstream workplace will not likely address the needs of the nonverbal adolescent with intellectual disability. For these reasons and more, more attention, more funding, should be focused on autism.

And we need to accept something that perhaps Congress doesn’t want to hear: we need to be in this for the long haul. We need a long term focus on autism. Since my child was first diagnosed I have heard simplistic answers from groups in and like those in the Coalition. If it was all so simple as “it’s vaccines and here is the cure of the day for vaccine injury” this discussion would not be ongoing. But it’s not. The simplistic approach offered by the Coaltion has been and continues to be a false path. We need to lay the groundwork to understand the biology behind autism. We need to understand the supports needed by this population–diverse in presentation and age. And this is no easy task. For decades people have recognized that autism is not a single condition.

Has the CAA succeeded? In very simplistic terms, the funding level for autism research has grown since the first CAA was enacted in 2006. When Federal stimulus funds became available, there was a Strategic Plan in place to justify allocating a large amount of those funds to autism research. As funding levels have declined, autism has been able to hold relatively steady. Can we say with certainty that the CAA is responsible for this? Possibly not, but it seems very likely. And for that I thank congress.

There’s an old saying in the science community: there’s more politics in science than science in politics. We need less politics in autism science, not more. There’s a line between advocacy and politics. One example where that line is being crossed has been the Oversight hearings focused on vaccines. They have been damaging to the communities. Another is the plan to make members of the IACC politically appointed by Congress. Another is the repeated efforts to keep the vaccine-epidemic idea alive through political action, while the idea has failed scientifically.

We need a mechanism whereby funding can be channeled to quality researchers who are working on topics which will improve the lives of all autistics. I hope we can keep the focus on that and not on how to increase the political presence of a few parent advocates with failed ideas. Don’t get me wrong: the current structure is far from ideal. But as we create a new structure, let’s keep ourselves focused on the real needs of the entire community.

Matthew J. Carey

Andrew Wakefield, apparently he’s making films to convince you that doctors think vaccines cause autism and are covering it up.

28 May

It can be very interesting to hear what people say when they are in their home element. Ken Reibel showed this when he reported back from an AutismOne parent convention six years ago. More recently, we heard Jenny McCarthy accuse parents who don’t take her advice on alternative medicine of being victim moms who love the attention they get from having a disabled child. So much so that they won’t treat their children. So, with that in mind, I took the time to listen to a talk from this year’s AutismOne convention. The talk by Andrew Wakefield.

Andrew Wakefield, the doctor behind the MMR/autism scare of the 1990’s, spoke at the AutismOne parent convention last week. His talk at AutismOne was The Legacy of Vaccine Injury. It’s much of the same non-autism talk about vaccines one reads online. But one minute of the talk stood out for me. A minute where he describes why he is making films.

Yes, in case you weren’t aware, Mr. Wakefield has a new career as a film maker. He has a documentary on the death of an autistic young man, Alex Spourdalakis. Mr. Spourdalakis was brutally murdered by his mother and caregiver. Mr. Wakefield, as it turns out, had been “helping” the family and was filming their story. That film is finished. Mr. Wakefield tells us why he makes his films in his AutismOne talk. One might ask: is it to demonstrate the needs of autistics? The challenges parents of autistics face? The lack of supports for autistics?

No. It’s best to get it straight from him (although I admit the title of this article gives it away). With that in mind, here’s my best effort at transcribing what he says. For context: he’s speaking to an audience of autism parents at AutismOne, and he’s been talking about how surveys/studies show a sizable minority of the U.S. population believes that vaccines cause autism:

“And there is no mention in these studies of the uncertain or the undecided. There was another poll* that came out, I think from the University of Chicago, in fact. Where they asked the question: ‘Do you believe doctors think that vaccines cause autism and are covering it up?’ 20% of the respondents said yes. The important number is that 36% didn’t know. And it’s that 36% that I am targeting in the films that I am making. They are not for you. You already know. I’d be honored if you watched them but they are not for you. They are for the agnostic. And for that reason they must get out into the mainstream.”

For that reason they must get out into the mainstream

“That reason”: convincing the agnostic that doctors think that vaccines cause autism and they are covering it up. Alex Spourdalakis died a horrific death, and that can be used in this campaign, by inserting him into one of Mr. Wakefield’s films.

Go ahead and listen. It’s about 9 minutes in this video (for some reason the embed code isn’t working so you have to follow the link).

And some people wonder why I am critical of Mr. Wakefield. Yeah, I know that criticizing Mr. Wakefield plays directly into the persona he has created, where he has given everything for the children. But in this case the time as well as the criticism is well deserved.


By Matt Carey

*In case you are wondering: he appears to be referring to Medical Conspiracy Theories and Health Behaviors in the United States.

A bill to establish a grant program to help State and local law enforcement agencies reduce the risk of injury and death relating to the wandering characteristics of some children with autism and other disabilities.

28 May

A bill has been introduced into the Senate: A bill to establish a grant program to help State and local law enforcement agencies reduce the risk of injury and death relating to the wandering characteristics of some children with autism and other disabilities. The text of the legislation has not been uploaded to to Thomas as of yet. There are only two sponsors for the bill: Charles E. Schumer and Joe Donnelly. By comparison, the Combating Autism Reauthorization Act of 2014 has 68 sponsors.

I’ll watch for the text of the language. Wandering and elopement has been an area of high focus in the autism parent communities.


By Matt Carey

ASAN: ACTION ALERT: Call On Congress to Oppose H.R. 4631, the Combating Autism Re-Authorization Act

28 May

The Autistic Self Advocacy Network (ASAN) has put out an action alert on changes they would like to see in the Combating Autism Re-Authorization Act:

ACTION ALERT: Call On Congress to Oppose H.R. 4631, the Combating Autism Re-Authorization Act

Tomorrow, the House Energy & Commerce Health Subcommittee will be taking a step to advance H.R. 4631, which would reauthorize the Combating Autism Act. The current version of the bill continues to exclude autistic people from the federal committee that oversees autism research (the Interagency Autism Coordinating Committee), continues the use of offensive language and politicizes appointments to the IACC.

Call your Member of Congress today at the Capitol Switchboard at (202) 224-3121 to say that we want real reforms. The operator will be able to use your zip code to connect you with your Representative. Urge them to oppose H.R. 4631 until such time as real reforms are put in place. Here are some talking points you can use:

1) H.R. 4631 continues to use language offensive to Autistic people and our allies. We don’t want to be “combated” – we want to be supported and respected. Despite numerous complaints by the Autistic community, the legislation continues to use disrespectful and offensive language. This has to change.

2) H.R. 4631 adds four congressionally appointed members to the Inter-Agency Autism Coordinating Committee, politicizing the IACC instead of letting it focus on analyzing autism research and policy from an objective perspective.

3) H.R. 4631 fails to require additional self-advocate representation on the IACC. Shouldn’t a government advisory committee about autism require more than one autistic representative on the committee? Tell Congress that they shouldn’t be acting about us, without us.

We want a real focus on research about services and the needs of adults, respectful language, and real representation of autistic people in decisions about where research dollars are needed. Act today by calling your Representative at (202) 224-3121.

TPGA: John Robison at IMFAR: On Autism Rights, Ethics, & Priorities

23 May

The Thinking Person’s Guide to Autism has posted a transcription of John Elder Robison’s talk at the recent IMFAR conference. The article is: John Robison at IMFAR: On Autism Rights, Ethics, & Priorities. Mr. Robison spoke in the Social, Legal and Ethical Research Special Interest Group.

Here is the TPGA introduction:

John Elder Robison was a discussant for the Autism Social, Legal, and Ethical Research Special Interest Group at the 2014 International Meeting for Autism Research (IMFAR). He ended up taking the group to task, stating that the autism science community is headed for disaster if it does not change course on several factors – and noting for context the larger size of the US autistic community in proportion to other minority groups such as Jewish or Native American communities. Mr. Robison asserted that autistic people need to be the ones providing oversight and governance for autism research. He condemned the use of words like “cure.” He pointed out that researchers’ explicit or implicit efforts to eradicate autistic people is a formula for disaster and needs to stop. And he affirmed that memoirs and narratives written by autistic people are more trustworthy than writing about autism by nonautistics.

Many thanks to IMFAR participant and community member Todd Melnick for transcribing this talk.

The full transcription can be read at John Robison at IMFAR: On Autism Rights, Ethics, & Priorities

Small groups band together to attempt to derail autism research funding

21 May

The law that sets in place the structure to steer autism research is up for renewal this year. Public Law 109-406 was introduced as The Combating Autism Act in 2006. It was reauthorized in 2011. And it is up for reauthorization again this year.

The law authorizes congress to appropriate $190,000,000 per year for autism research. But there are those who would like to scuttle this effort.

A number of groups have banded together to form the “Autism Policy Reform Coalition” to oppose continuing with the law funding autism research. From The Hill:

But an upstart group known as the Autism Policy Reform Coalition (APRC) is against the bill, arguing a drastic overhaul is needed in order for the money to be used effectively.

Who are the “Autism Policy Reform Coalition”? Readers to Left Brain/Right Brain will likely recognize many of these groups. And quickly put together the link that ties them together. In case you haven’t already guess it, yes, it’s vaccines. With science against them on vaccines, they are trying to legislate their views into existence.

Many of these groups are very small. Well funded, but small. None has a truly large membership. Most if not all do not allow for their leadership to be selected by a vote of membership. In fact, for most it seems one can not join them as a member, so it’s difficult to understand how they claim to represent a large part of the autism communities. As far as I know, none have an autistic in any prominent position, much less as a leader. And yet they purport to represent the “autism community”.

While many of these groups have toned down their public statements on vaccines over the years, they are still heavily invested in the idea. One marker of their support for the idea and their lack of scientific rigor is their support for Andrew Wakefield. Mr. Wakefield is the disgraced former academic surgeon who lost his medical license for unethical behavior and whose work attempting to link the MMR vaccine with autism was declared one of the great science frauds by Time Magazine. Much more, his work has been shown to be wrong (for one example, here).

Here are the groups in the Autism Policy Coalition:

Autism is Medical

Appears to be involved with Andrew Wakefield and the failed vaccine-causation notion. They are relatively new having just received 501(c)(3) status this year.

Defending Academic Integrity and Research Foundation
Again, a new group. They appear to be in place in large part to give financial assistance to Andrew Wakefield’s lawsuit against Brian Deer and the BMJ (replacing the “Doctor Wakefield Justice Fund”).

Here’s a recent Facebook page post

D.A.I.R. Foundation is committed to integrity in academics and research and exists to support scientists, doctors, and researchers working in the best interest of the public health whose efforts have come under intense and unfair scrutiny.

At the heart of this is Dr. Andy Wakefield whose work challenged special interest groups who responded with opposition and injustice. The Weston A Price Foundation awarded Dr. Wakefield the prestigious Integrity in Science award at the 2013 Wise Traditions Conference where he was also keynote speaker at the banquet. The DAIR Foundation Fundraiser seeks to provide legal support for Dr Wakefield and others in similar situations. We welcome your support. Tickets are tax deductible and attendees receive cocktails, dinner from a Paleo-style buffet, and a copy of Dr Wakefield’s latest book. Dr. Wakefield will speak to dinner guests about his research and his documentary movie.

To purchase tickets visit the DAIR Foundation website and click on the envelope icon next to the text Orlando Fundraiser Event

It is unclear how one would become a member, voting or not, of DAIR, nor how their leadership is selected.

Generation Rescue

Generation Rescue is currently run by Jenny McCarthy, who has been very vocal in her support of the vaccine/autism link. When Andrew Wakefield lost his job at Thoughtful House, Generation Rescue stepped up with a $100,000 donation to his “Strategic Autism Initiative”.

Generation Rescue’s founder wrote:

With less than a half-dozen full-time activists, annual budgets of six figures or less, and umpteen thousand courageous, undaunted, and selfless volunteer parents, our community, held together with duct tape and bailing wire, is in the early to middle stages of bringing the U.S. vaccine program to its knees.

I can not find from their website whether one can join as a member (voting or not) or how their leadership is selected.

National Autism Association

Recently ran into controversy over a fundraiser for their stance on vaccines. Supporter of Andrew Wakefield. They state on their website:

The National Autism Association believes:
Vaccinations can trigger or exacerbate autism in some, if not many, children, especially those who are genetically predisposed to immune, autoimmune or inflammatory conditions.

One can become a dues-paying member of the NAA. Their most recent IRS form 990 shows that they took in $4,775 in dues. That would be fewer than 150 dues paying members at their $35 tier.

I can not see how leadership is selected; whether the membership is allowed to vote in open elections.

SafeMinds

One of the first organizations formed around the idea that vaccines cause autism. In specific, SafeMinds is focused on thimerosal in vaccines. The leadership has many of the same people over the past decade and I can’t see where one could join and whether if members are allowed, if they are allowed to vote for leadership.

Talk About Curing Autism

Another org that is strongly behind the vaccine-autism link.
(and here). It’s unclear if or how one would become a voting member. The leadership has been largely unchanged since founding.

The Thinking Mom’s Revolution

While I’m very fond of blogs, I don’t see them as organizations. Again, where does one join or vote for leadership? How does this blog count membership? Facebook likes?

I believe every one of the above groups considers Andrew Wakefield to be a hero, ignoring his proved ethical lapses (he was stripped of his medical license and the fact that his ideas on vaccines and autism have been shown to be wrong (e.g. Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study to select one of many)

I am a public member to the IACC, which was set up by the reathorization in 2011. All views above (and anywhere) are my own. While there are certainly things I would hope could be done differently in the way the U.S. manages autism research, handing control over to a few small groups so they can push a failed agenda on vaccines is not the direction we should go. Scuttling the reauthorization because support is not going into further research on this failed idea is also not the direction we need to take. Not at all.

It’s very telling that these groups for the most part hide or downplay their position on vaccines. The NAA, for example, recently ran into controversy about their stance and lost a fundraising opportunity with the national restaurant chain Chilis. The NAA leadership paid lip service to effect that the statements on their website are old views, but those statements remain. They know this position is a liability in public. But rather than accept that the view is a liability for good reason, they chose to downplay their views.

I don’t know if many in the legislature are giving them a serious listen, but I hope not. These groups do not represent the autism communities. They certainly are not showing an effective leadership, working to scuttle a law and lose hundreds of millions of dollars in funding if their own failed ideas are not supported.


By Matt Carey

Committee on Oversight & Government Reform, subcommittee hearing on autism

20 May

The U.S. House of Representatives, Committee on Oversight & Government Reform, Subcommittee on Government Operations held a hearing today: Examining the Federal Response to Autism Spectrum Disorders. That hearing was live streamed and the video is now available online:



Broadcast live streaming video on Ustream

The hearing focused on a recent Government Accountability Office report: FEDERAL AUTISM ACTIVITIES: Funding and Coordination Efforts.

IACC releases 2013 Strategic Plan Update

20 May

The U.S. Interagency Autism Coordinating Committee releases each year an update the Strategic Plan for ASD Research. This year’s update differs from previous years in that the format was more retrospective: an accounting of the changes in research and understanding in the past five years.

Below is the press release from the Office of Autism Research Coordination announcing the update:

2013 IACC Strategic Plan Update Provides Accounting of ASD Research Progress Over Last 5 Years (pdf-45KB)

The Interagency Autism Coordinating Committee (IACC) has released its 2013 Strategic Plan Update, which provides an overview of funding and scientific advances made in autism research since 2009, when the IACC Strategic Plan for ASD Research was first published. Approximately $1.5 billion has been dedicated to ASD research over the past 5 years through the combined efforts of U.S. government agencies and private organizations. The 2013 Strategic Plan Update describes funding trends and research advances that capture the significant progress that has been made in all seven critical research areas of the Strategic Plan over the past 5 years, providing an accounting for which funding and research goals have been achieved and identifying key areas where intensified efforts are warranted.

IACC Chair and NIMH Director Dr. Thomas Insel said, “The state of the science has dramatically changed in the ASD field over the last 5 years. The 2013 Strategic Plan Update provides an accounting of that change, through investments and the evolution of research since the 2009 publication of the original Strategic Plan. This investment has translated to progress in all seven research areas outlined by the Plan,” which include risk factors, treatments and interventions, services, lifespan issues, and surveillance and infrastructure.

Since the release of the first IACC Strategic Plan in 2009, scientific advances have been made in the understanding of the key windows of fetal and infant development, when changes in gene expression, brain architecture and behavior can be linked to the later development of autism, along with potential environmental contributors to ASD risk such as parental age, maternal health conditions and prematurity. Advances have also been made in the development of new and improved screening tools, demonstration of the efficacy of various early intervention strategies, and increased information about critical services gaps, such as transition and housing, as well as data supporting effective services strategies. Research infrastructure has also greatly expanded in the past 5 years, with shared data repositories providing an unprecedented opportunity for collaboration and large-scale data analysis.

In most research areas, including those where funding fully met recommendations, the Committee suggested that additional investment would be needed to fully achieve the aspirational goals of making appropriate diagnosis, intervention and services available to all individuals with ASD, including people of all ages, cultural groups and levels of ability.

The 2013 Update identified several overarching themes that have emerged and that the Committee felt were critical for accelerating the progress of ASD research in the next 5 years. These include:

Scaling up screening tools, interventions, and services approaches for transition from lab to community settings.
Promoting inclusion of research subjects from the full range of ASD disability, from all periods of the lifespan, and from underserved populations.
Translating “practice to research,” by encouraging study of current real-world practices to inform research studies.
Characterizing the heterogeneity of ASD, including genotypes, subtypes, and co-morbid health conditions, in order to develop a personalized medicine approach.
Leveraging existing infrastructure to increase research speed and efficiency.
Applying strategies from other fields to ASD research.
Standardizing the ways in which outcomes are measured in clinical trials and services research to determine the effectiveness of interventions and services.
In the 2013 Strategic Plan Update, the IACC provides the most detailed accounting to date, using both quantitative and qualitative data. This included review of detailed portfolio analysis data and the literature, as well as consultation with over 25 external experts and review of comments received from the public, to assess progress across all objectives and aspirational goals described in the Strategic Plan since its initial conception.

Overall, the Committee hopes that this latest IACC Strategic Plan Update will provide Congress, federal agencies, advocates, and people with autism and their families with helpful information about important research progress that has been made to date, as well as areas that need further attention, in order to support a robust research effort that will lead to enhanced interventions, services and opportunities for people with autism across cultures, across the full spectrum of ability, and across the lifespan.


By Matt Carey

note: I serve as a public member to the IACC but my comments here and elsewhere are my own

Hearing tomorrow on Examining the Federal Response to Autism Spectrum Disorders

19 May

The Committee on Oversight and Government Reform through the subcommittee on Government Operations will be holding a hearing tomorrow (May 20): Examining the Federal Response to Autism Spectrum Disorders

Testifying will be:

Thomas R. Insel, M.D.
Director, National Institute of Mental Health
Chair, Interagency Autism Coordinating Committee

Mr. Michael K. Yudin
Acting Assistant Secretary, Office of Special Education and Rehabilitative Services
U.S. Department of Education

Marcia Crosse, Ph.D.
Director, Health Care
U.S. Government Accountability Office

Likely this is based partly on the Government Accountability Office report last year: Better Data and More Coordination Needed to Help Avoid the Potential for Unnecessary Duplication and the introduction of the reauthorization bill for the Combating Autism Act.


By Matt Carey

ASAN Letter Expressing Concern re: House Subcommittee Hearing on Autism

18 May

A hearing has been scheduled for next week with the Committee on Oversight and Government Reform for it’s Subcommittee on Government Operations.

The hearing, Examining the Federal Response to Autism Spectrum Disorders, is scheduled for Tuesday, May 20, 2014.

The Autistic Self Advocacy Network (ASAN) has issued a letter expressing concern over the apparent lack of autistic input to the hearing. That letter is quoted below.

ASAN Letter Expressing Concern re: House Subcommittee Hearing on Autism

May 17, 2014
Dear Chairman Mica and Ranking Member Connolly:

On behalf of the Autistic Self Advocacy Network, the nation’s leading advocacy organization run by and for autistic people, I write to express concern about the upcoming May 20th, 2014 Subcommittee on Government Operations hearing entitled “Examining the Federal Response to Autism Spectrum Disorders.” To our knowledge, no autistic witnesses or representatives from organizations run by Autistic people have been invited to testify. ASAN is profoundly concerned by the apparent absence of representatives from organizations run by autistic people and urges that the hearing not go forward without representation by those most directly impacted by federal autism policy.

Autistic individuals are uniquely suited to testify about which federal activities are most needed in order to improve our own lives. Accordingly, when the House Committee on Oversight and Government Reform proposed a hearing on autism in November 2012, ASAN and other disability rights organizations voiced strong opposition to the planned absence of witnesses from organizations run by autistic people at that hearing and was pleased when the organizers of that hearing responded by inviting two autistic witnesses representing organizations run by autistic people to testify. The presence of autistic voices at the November 2012 hearing helped to enrich the conversation about the federal government’s response to autism.

We are disappointed by the prospect that, to our knowledge, the Committee has not invited Autistic witnesses from organizations run by autistic people to the upcoming hearing. It would truly be unfortunate if the progress Congress made in 2012 were reversed in 2014. ASAN appreciates the Subcommittee’s interest in federal autism policy and urges it to ensure the inclusion of witnesses from organizations run by and for autistic adults in its witness list. We stand ready to assist the Subcommittee in its efforts. If we can be of any assistance, please feel free to contact us via ASAN’s Director of Public Policy, Samantha Crane, at scrane@autisticadvocacy.org.

Sincerely,

Ari Ne’eman
President
Autistic Self Advocacy Network

cc: Chairman Darrell E. Issa
cc: Ranking Member Elijah Cummings